Mr. William L Hogan, M.S., P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 235lakemont Rd, Newport, VT 05855 Phone: 802-334-8558 Fax: 802-334-8559 |
Shawn Moore Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 35 Bel Aire Dr, Newport, VT 05855 Phone: 802-334-2878 |
Lindsay L O'steen, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 81 Medical Village Dr, Suite 3, Newport, VT 05855 Phone: 802-334-3260 Fax: 802-334-4162 |
Heidi Laramee, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 81 Medical Village Dr, Newport, VT 05855 Phone: 802-334-3260 |
Carol Cassidy Lawlor, MED, PT, ATC, CSCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 251 Indian Point St, Newport, VT 05855 Phone: 802-334-5858 |
News Archive
UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection. Published in the April 12 edition of Science, the finding suggests new approaches to treating persistent viral infections like HIV and hepatitis C.
In the 1980s and 90s, Scotland was known for its alarmingly high suicide rate. But since 2000, suicide rates have fallen sharply. A study published in the online open access journal BMC Public Health found this reduction is associated with a significant drop in hangings as a means of suicide.
By injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second zap of a laser, a multi-institutional team of researchers from the Wake Forest University School of Medicine (WFUSOM), Wake Forest University Center for Nanotechnology and Molecular Materials, Rice University, and Virginia Polytechnic Institute and State University has developed a new type of therapy that effectively kills kidney tumors in nearly 80% of treated mice. Researchers say that the findings, which were published in the Proceedings of the National Academy of Sciences of the United States of America, suggest a potential future cancer treatment for humans.
South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic.
› Verified 8 days ago